Trial Profile
Efficacy of the Selctive COX-2-inhibitor Parecoxib on the Pathological Low Pressure Pain Threshold (PPT) of Patients With Complex Regional Pain Syndrome (CRPS).
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Parecoxib (Primary)
- Indications Complex regional pain syndromes
- Focus Therapeutic Use
- 03 Feb 2012 New trial record